Pfizer has maintained the same amount of revenues since 2010 which actually means it’s shrinking a bit (inflation) but this stock has a lot of value to offer. Their annual EPS is $2.80 and they pay out an annual dividend of $1.52 (4% yield) of which increases 16c every year. They have a healthy and steady Cash Flow of $4.20 and their shares outstanding have decreased at a 2-3% rate every year.
Pfizer is a Pharmaceutical company that develops and markets medicine for humans and animals valued at 200Bn
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.